The role of bone cytokine, CBFa-1, OPG and ODF in the mechanism of bone metastases with prostate cancers

骨细胞因子、CBFa-1、OPG、ODF在前列腺癌骨转移机制中的作用

基本信息

项目摘要

The mechanism for the osteoplastic metastases in prostate cancer is not clearly known but osteoplastic metastases might be correlated with the balance of osteoblast and osteoclast cell. The regulator factors of osteoblast and osteoclast cells (bone cytokine, OPG, ODF and CBFa-1) mignt have an important role in bone metastases. We evaluated the quantifcation of gene expression of bone regulator factors in the cancer cells. We removed only the cancer cells from the specimens of prostate cancer, bladder cancer and renal cell cancer using laser-captured microdissection. We measured the real-time RT-PCR quantification of BMP-2, BMP-6, CBFa-1, PHT-rP, ODF and OPG. The relative values of mRNA were presented as each factors/β-actin ×1000. The relative values of BMP-2, BMP-6, OPG, CBFa-1, PTH-rP and ODF ware 14.33±3.30,21.18±1.35,4.71±1.29,3.47±1.62,24.45±8.10 and 1.29±0.65 in prostate cancer, respectively. The BMP-2, BMP-6, OPG, CBFa-1, PTH-rP and ODF were 0.95±0.20,1.30±0.60,1.52±0.36,0.55±0.36,0.29±0.13 and 2.20±1.28 in renal cell cancer, respectively. The mRNA expression of BMP-2, BMP-6, OPG, CBFa-1, PTH-rP and ODF were 1.19±0.56,0.18±0.11,0.26±0.14,0.62±0.20,0.12±0.06 and 0.13±0.09 in bladder cancer, respectively. The relative OCIF, PTH-rP and BMP-2, BMP-6 values in prostate cancer were significantly higher than that in bladder cancer and renal cell cancer. The relative BMP-2, BMP-6 and PTH-rP values were significantly higher than other factors in prostate cancer. The regulator factors of bone formation might be an essential role in mechanism of bone metastases from prostate cancer. Elucidating the mechanism of bone metastasis will be useful to treat the advanced prostate cancer.
前列腺癌骨转移的机制尚不清楚,但骨转移可能与成骨细胞和破骨细胞的平衡有关。成骨细胞和破骨细胞的调节因子(骨细胞因子、OPG、ODF和CBFa-1)可能在骨转移中起重要作用。我们评估了骨调节因子在癌细胞中的基因表达的定量。我们使用激光捕获显微切割技术仅从前列腺癌、膀胱癌和肾细胞癌标本中去除癌细胞。我们测量了BMP-2、BMP-6、CBFa-1、PHT-rP、ODF和OPG的实时RT-PCR定量。mRNA的相对值表示为每个因子/β-actin ×1000。前列腺癌中BMP-2、BMP-6、OPG、CBFa-1、PTH-rP和ODF的相对值分别为14.33± 3.30、21.18 ± 1.35、4.71 ± 1.29、3.47 ± 1.62、24.45 ±8.10和1.29±0.65。肾细胞癌中BMP-2、BMP-6、OPG、CBFa-1、PTH-rP和ODF的表达分别为0.95± 0.20、1.30 ± 0.60、1.52 ± 0.36、0.55 ± 0.36、0.29 ±0.13和2.20±1.28。BMP-2、BMP-6、OPG、CBFa-1、PTH-rP和ODF的mRNA表达分别为1.19± 0.56、0.18 ± 0.11、0.26 ± 0.14、0.62 ± 0.20、0.12 ±0.06和0.13±0.09。前列腺癌组织中OCIF、PTH-rP和BMP-2、BMP-6的相对值均显著高于膀胱癌和肾癌组织。BMP-2、BMP-6和PTH-rP的相对值在前列腺癌中显著高于其他因子。骨形成的调节因子可能在前列腺癌骨转移的发生机制中起重要作用。阐明前列腺癌骨转移的发生机制,将有助于晚期前列腺癌的治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAKIHANA Yoshio其他文献

TAKIHANA Yoshio的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Multi-lab validation of a real-time PCR assay for detection and surveillance of SARS-CoV-2 for companion animal applications.
对用于伴侣动物应用的 SARS-CoV-2 检测和监测的实时 PCR 检测进行多实验室验证。
  • 批准号:
    10828972
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Urgent replacement of real-time PCR machine
紧急更换实时荧光定量PCR仪
  • 批准号:
    RTI-2023-00026
  • 财政年份:
    2022
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Research Tools and Instruments
Replacement quantitative real-time PCR detection system for studies in parasitology, animal physiology and environmental toxicology
用于寄生虫学、动物生理学和环境毒理学研究的替代定量实时 PCR 检测系统
  • 批准号:
    RTI-2022-00063
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Research Tools and Instruments
Development of multiplex real-time PCR assays for differentiating SARS-CoV-2 from other respiratory and enteric pathogens
开发多重实时 PCR 检测方法以区分 SARS-CoV-2 与其他呼吸道和肠道病原体
  • 批准号:
    10449687
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
Replacement of automated real-time PCR cluster
更换自动化实时 PCR 集群
  • 批准号:
    RTI-2021-00413
  • 财政年份:
    2020
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Research Tools and Instruments
RADX TECH PROJECT #4554: UBIQUITOME SARS-COV-2 LAB TEST ACCURACY WITHIN REACH OF EVERY AMERICAN WITH LIBERTY16 MOBILE REAL TIME PCR
RADX 技术项目
  • 批准号:
    10505996
  • 财政年份:
    2020
  • 资助金额:
    $ 2.24万
  • 项目类别:
Development of COVID-19 Dual Diagnostic Test of Viral RNA and Proteins using DNA Aptamers and Real-Time PCR
使用 DNA 适体和实时 PCR 开发病毒 RNA 和蛋白质的 COVID-19 双重诊断测试
  • 批准号:
    550320-2020
  • 财政年份:
    2020
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Alliance Grants
High throughput real-time PCR instrument for studies of host responses to pathogens and cancer
高通量实时 PCR 仪器,用于研究宿主对病原体和癌症的反应
  • 批准号:
    RTI-2021-00604
  • 财政年份:
    2020
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Research Tools and Instruments
High Throughput Real-Time PCR (qPCR) for AAC Genomics Core Lab
AAC 基因组学核心实验室的高通量实时 PCR (qPCR)
  • 批准号:
    RTI-2020-00643
  • 财政年份:
    2019
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Research Tools and Instruments
ShEEP Request for QuantStudio 12K Flex Real-Time PCR system
ShEEP 请求 QuantStudio 12K Flex 实时 PCR 系统
  • 批准号:
    9796289
  • 财政年份:
    2019
  • 资助金额:
    $ 2.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了